| Caplin Point Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524742 |
NSE Symbol : CAPLIPOINT |
P/E(TTM) : 41.51 |
|
ISIN Demat : INE475E01026 |
Div & Yield% : 0.31 |
EPS(TTM) : 46.00 |
|
Book Value(₹) : 242.54 |
Market Cap(₹Cr) : 14,515.57 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 752.41 | 625.09 | 528.61 | 528.06 | 482.68 |
| Other Income | 134.59 | 105.84 | 99.00 | 56.55 | 18.62 |
| Stock Adjustments | -24.36 | 43.68 | 1.67 | 9.00 | 0.57 |
| Total Income | 862.64 | 774.61 | 629.28 | 593.61 | 501.87 |
| EXPENDITURE : | |||||
| Raw Materials | 213.81 | 248.90 | 199.73 | 213.65 | 195.40 |
| Power and Fuel Cost | 14.11 | 15.43 | 9.89 | 9.54 | 6.36 |
| Other Manufacturing Expenses | 24.00 | 25.43 | 13.73 | 10.81 | 7.75 |
| Selling and Administration Expenses | 75.50 | 40.75 | 40.30 | 43.51 | 28.12 |
| Miscellaneous Expenses | 16.53 | 13.07 | 10.03 | 9.46 | 5.10 |
| Employee Benefit Expenses | 52.13 | 38.11 | 36.68 | 30.47 | 26.59 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 466.56 | 392.92 | 318.92 | 276.17 | 232.55 |
| Interest | 0.12 | 0.10 | 0.12 | 0.09 | 0.17 |
| Gross Profit | 466.44 | 392.82 | 318.80 | 276.08 | 232.38 |
| Depreciation | 24.77 | 27.08 | 25.65 | 25.77 | 22.44 |
| Profit Before Tax | 441.67 | 365.74 | 293.15 | 250.31 | 209.94 |
| Current Tax | 102.90 | 86.12 | 66.58 | 61.62 | 54.88 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.72 | -4.09 | -7.69 | 0.82 | -1.17 |
| Reported Net Profit | 339.49 | 283.71 | 234.26 | 187.87 | 156.23 |
| Extraordinary Items | -0.33 | 1.19 | 1.17 | 0.75 | 4.67 |
| Adjusted Net Profit | 339.82 | 282.52 | 233.09 | 187.12 | 151.56 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 1,333.49 | 1,083.95 | 880.01 | 714.84 | 561.64 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 37.99 | 34.17 | 30.32 | 22.70 | 3.03 |
| P & L Balance carried down | 1,634.99 | 1,333.49 | 1,083.95 | 880.01 | 714.84 |
| Dividend | 18.99 | 15.19 | 15.16 | 11.35 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 300.00 | 250.00 | 225.00 | 200.00 | 150.00 |
| Dividend Per Share(Rs) | 6.00 | 5.00 | 4.50 | 4.00 | 3.00 |
| Earnings Per Share-Unit Curr | 44.67 | 37.35 | 30.86 | 24.78 | 20.65 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 223.81 | 183.03 | 150.19 | 122.78 | 100.29 |
| Book Value(Adj)-Unit Curr | 223.81 | 183.03 | 150.19 | 122.78 | 100.29 |
